ES2407283T3 - Distracción de callo óseo artificial tridimensional - Google Patents
Distracción de callo óseo artificial tridimensional Download PDFInfo
- Publication number
- ES2407283T3 ES2407283T3 ES07818725T ES07818725T ES2407283T3 ES 2407283 T3 ES2407283 T3 ES 2407283T3 ES 07818725 T ES07818725 T ES 07818725T ES 07818725 T ES07818725 T ES 07818725T ES 2407283 T3 ES2407283 T3 ES 2407283T3
- Authority
- ES
- Spain
- Prior art keywords
- frame
- framework
- bone
- intermediate spaces
- fibers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 86
- 206010020649 Hyperkeratosis Diseases 0.000 title description 6
- 239000000463 material Substances 0.000 claims abstract description 139
- 239000000835 fiber Substances 0.000 claims abstract description 84
- 238000011069 regeneration method Methods 0.000 claims abstract description 19
- 230000008929 regeneration Effects 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 238000011049 filling Methods 0.000 claims abstract description 6
- 229920003023 plastic Polymers 0.000 claims abstract description 6
- 239000004033 plastic Substances 0.000 claims abstract description 6
- 238000011084 recovery Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 42
- 239000011148 porous material Substances 0.000 claims description 25
- 230000010478 bone regeneration Effects 0.000 claims description 19
- 230000008569 process Effects 0.000 claims description 16
- 239000003292 glue Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 11
- 229920000954 Polyglycolide Polymers 0.000 claims description 10
- 239000002131 composite material Substances 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 9
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 9
- 239000004633 polyglycolic acid Substances 0.000 claims description 9
- 239000004626 polylactic acid Substances 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 229920002732 Polyanhydride Polymers 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 5
- 108010035532 Collagen Proteins 0.000 claims description 5
- 229920001397 Poly-beta-hydroxybutyrate Polymers 0.000 claims description 5
- 229920000331 Polyhydroxybutyrate Polymers 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 5
- 229920001436 collagen Polymers 0.000 claims description 5
- 230000000035 biogenic effect Effects 0.000 claims description 4
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 claims description 4
- 102000009123 Fibrin Human genes 0.000 claims description 3
- 108010073385 Fibrin Proteins 0.000 claims description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 3
- 229950003499 fibrin Drugs 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 238000001125 extrusion Methods 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 53
- 230000007547 defect Effects 0.000 description 34
- 210000000963 osteoblast Anatomy 0.000 description 26
- 230000004048 modification Effects 0.000 description 22
- 238000012986 modification Methods 0.000 description 22
- 230000002950 deficient Effects 0.000 description 17
- 208000007536 Thrombosis Diseases 0.000 description 16
- 108090000765 processed proteins & peptides Proteins 0.000 description 15
- 239000011248 coating agent Substances 0.000 description 14
- 238000000576 coating method Methods 0.000 description 14
- 229920000642 polymer Polymers 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 238000006073 displacement reaction Methods 0.000 description 9
- 210000002950 fibroblast Anatomy 0.000 description 9
- 239000011257 shell material Substances 0.000 description 9
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 8
- 239000000316 bone substitute Substances 0.000 description 8
- 230000008602 contraction Effects 0.000 description 8
- 230000011164 ossification Effects 0.000 description 8
- 230000005540 biological transmission Effects 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 6
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 6
- 210000002744 extracellular matrix Anatomy 0.000 description 6
- 239000000017 hydrogel Substances 0.000 description 6
- 238000002513 implantation Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 210000005009 osteogenic cell Anatomy 0.000 description 5
- 102000016359 Fibronectins Human genes 0.000 description 4
- 108010067306 Fibronectins Proteins 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 230000000735 allogeneic effect Effects 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- -1 ethyl hydroxyl Chemical group 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000021164 cell adhesion Effects 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 210000002889 endothelial cell Anatomy 0.000 description 3
- 210000001650 focal adhesion Anatomy 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000009103 reabsorption Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 102000006495 integrins Human genes 0.000 description 2
- 108010044426 integrins Proteins 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 230000002188 osteogenic effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 238000012876 topography Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002965 anti-thrombogenic effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000002016 colloidosmotic effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 210000001608 connective tissue cell Anatomy 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000009799 cystectomy Methods 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000009442 healing mechanism Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920002627 poly(phosphazenes) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000003980 solgel method Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006047248 | 2006-10-06 | ||
| DE102006047248A DE102006047248B4 (de) | 2006-10-06 | 2006-10-06 | Dreidimensionale künstliche Kallusdistraktion |
| PCT/EP2007/008648 WO2008043484A2 (de) | 2006-10-06 | 2007-10-05 | Dreidimensionale künstliche kallusdistraktion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2407283T3 true ES2407283T3 (es) | 2013-06-12 |
Family
ID=39154578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES07818725T Active ES2407283T3 (es) | 2006-10-06 | 2007-10-05 | Distracción de callo óseo artificial tridimensional |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8834577B2 (enExample) |
| EP (1) | EP2079391B1 (enExample) |
| JP (1) | JP5099650B2 (enExample) |
| CN (1) | CN101610732B (enExample) |
| DE (1) | DE102006047248B4 (enExample) |
| ES (1) | ES2407283T3 (enExample) |
| WO (1) | WO2008043484A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040081704A1 (en) * | 1998-02-13 | 2004-04-29 | Centerpulse Biologics Inc. | Implantable putty material |
| US7771482B1 (en) | 2000-05-09 | 2010-08-10 | Ben-Zion Karmon | Method for tissue expansion and regeneration using bioresorbable inflatable devices |
| US20020114795A1 (en) * | 2000-12-22 | 2002-08-22 | Thorne Kevin J. | Composition and process for bone growth and repair |
| US7166133B2 (en) | 2002-06-13 | 2007-01-23 | Kensey Nash Corporation | Devices and methods for treating defects in the tissue of a living being |
| US7718616B2 (en) | 2006-12-21 | 2010-05-18 | Zimmer Orthobiologics, Inc. | Bone growth particles and osteoinductive composition thereof |
| DE102008014560A1 (de) * | 2008-03-15 | 2009-09-24 | Celgen Ag | Vorrichtung, umfassend ein Quellmittel und eine Ummantelung, zur künstlichen Kallusdistraktion |
| WO2009115251A1 (de) * | 2008-03-15 | 2009-09-24 | Celgen Ag | Vorrichtung, umfassend ein quellmittel und eine ummantelung, zur künstlichen kallusdistraktion |
| JP2010125156A (ja) * | 2008-11-28 | 2010-06-10 | Olympus Corp | 移植材とその製造方法 |
| MX2011007080A (es) * | 2008-12-31 | 2011-10-17 | Kci Licensing Inc | Sistema para inducir el flujo de fluido para estimular el crecimiento de tejido. |
| DE102009042493B4 (de) | 2009-09-14 | 2016-07-21 | Celgen3D Ag | Granulatmischung, umfassend zwei verschiedene Granulate, zur künstlichen Kallusdistraktion |
| AU2011329054B2 (en) | 2010-11-15 | 2015-05-28 | Zimmer Orthobiologics, Inc. | Bone void fillers |
| DE102011014789A1 (de) | 2011-03-14 | 2012-09-20 | Celgen Ag | Granulatmischung, umfassend zwei verschiedene Granulate, zur künstlichen Kallusdistraktion |
| WO2013023064A2 (en) * | 2011-08-09 | 2013-02-14 | New Jersey Institute Of Technology | Composite matrix for bone repair applications |
| WO2017003461A1 (en) | 2015-06-30 | 2017-01-05 | University Of South Florida | Osteoconductive and osteoinductive implant for augmentation, stabilization, or defect reconstruction |
| IL243401A (en) | 2015-12-29 | 2017-12-31 | Zion Karmon Ben | Instruments and methods for lifting Schneider membrane |
| IL248472A0 (en) | 2016-10-13 | 2017-01-31 | Zion Karmon Ben | Devices for tissue growth |
| EP3668457B1 (de) | 2017-10-17 | 2023-06-07 | Nicolas Perren | Vorrichtung zur nicht-invasiven induktion dynamischer deformation von körpergewebe zur differenzierung von gewebezellen |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2833717B2 (ja) * | 1990-06-01 | 1998-12-09 | イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー | 弾性率変化のある複合整形外科インプラント |
| DE59108588D1 (de) * | 1991-08-07 | 1997-04-10 | Oscobal Ag | Endoprothese mit einem Metalldrahtwerk |
| CA2117379C (en) * | 1992-02-14 | 1999-11-16 | Kypriacos A. Athanasiou | Multi-phase bioerodible implant/carrier and method of manufacturing and using same |
| KR100414961B1 (ko) * | 1994-12-19 | 2004-06-24 | 세피텍 파운데이션 | 섬유강화열가소성재료로제조된부품의제조방법및그방법에의해제조된부품 |
| DE19706667A1 (de) * | 1997-02-20 | 1998-08-27 | Merck Patent Gmbh | Knochenersatzmaterial mit einer Oberflächenbelegung mit Peptiden mit RGD-Aminosäuresequenz |
| US6113599A (en) * | 1997-06-04 | 2000-09-05 | Kalpa Engineering, Inc. | Apparatus for internal mandibular distraction |
| US6350284B1 (en) * | 1998-09-14 | 2002-02-26 | Bionx Implants, Oy | Bioabsorbable, layered composite material for guided bone tissue regeneration |
| AU766735B2 (en) * | 1998-09-15 | 2003-10-23 | Isotis N.V. | Osteoinduction |
| US8137103B1 (en) * | 1999-05-13 | 2012-03-20 | University Of Connecticut | Implant system |
| US6280191B1 (en) * | 1999-09-03 | 2001-08-28 | Christopher B. Gordon | Distractor suitable for permanent implantation into bone |
| EP1263485B1 (en) * | 2000-03-09 | 2005-03-02 | Syntacoll AG | Multilayer collagen matrix for tissue reconstruction |
| EP1745759B1 (de) * | 2000-05-29 | 2009-05-06 | CelGen AG | Medizinische Membranen zur Knochenregeneration |
| US7052517B2 (en) * | 2000-10-24 | 2006-05-30 | Vita Special Purpose Corporation | Delivery device for biological composites and method of preparation thereof |
| FI20010540A0 (fi) * | 2001-03-16 | 2001-03-16 | Yli Urpo Antti | Komposiitti pehmyt- ja kovakudosvammojen korjaamiseksi ja mainitun komposiitin käyttö |
| WO2002101385A1 (en) * | 2001-06-13 | 2002-12-19 | Massachusetts Institute Of Technology | In vivo bioreactors |
| IL144446A0 (en) * | 2001-07-19 | 2002-05-23 | Prochon Biotech Ltd | Plasma protein matrices and methods for their preparation |
| US6758673B2 (en) * | 2001-12-05 | 2004-07-06 | Ofir Fromovich | Periosteal distraction |
| US20050118236A1 (en) * | 2002-12-03 | 2005-06-02 | Gentis Inc. | Bioactive, resorbable scaffolds for tissue engineering |
| JP4717336B2 (ja) * | 2003-08-06 | 2011-07-06 | グンゼ株式会社 | 骨再生用基材およびその製造法 |
| US20050074437A1 (en) | 2003-10-06 | 2005-04-07 | Domonkos Horvath | Device for the regeneration of tissue, specifically bone regeneration by means of callus distraction |
| US7723395B2 (en) * | 2004-04-29 | 2010-05-25 | Kensey Nash Corporation | Compressed porous materials suitable for implant |
| WO2005089828A1 (ja) * | 2004-03-22 | 2005-09-29 | The New Industry Research Organization | 生分解性樹脂複合材料により構成される組織再生用足場（スカフォールド） |
| DE102004045410A1 (de) * | 2004-09-15 | 2006-03-30 | Glatt Gmbh | Knochenersatzimplantat für human- und veterinärmedizinische Anwendungen |
| CN101060821A (zh) * | 2004-09-21 | 2007-10-24 | 麻省理工学院 | 梯度支架及其制备方法 |
| WO2006088866A2 (en) * | 2005-02-14 | 2006-08-24 | Indiana University Research And Technology Corporation | Biodegradable load-bearing carrier for bone regeneration |
-
2006
- 2006-10-06 DE DE102006047248A patent/DE102006047248B4/de not_active Expired - Fee Related
-
2007
- 2007-10-05 EP EP07818725A patent/EP2079391B1/de not_active Not-in-force
- 2007-10-05 ES ES07818725T patent/ES2407283T3/es active Active
- 2007-10-05 WO PCT/EP2007/008648 patent/WO2008043484A2/de not_active Ceased
- 2007-10-05 JP JP2009530808A patent/JP5099650B2/ja not_active Expired - Fee Related
- 2007-10-05 CN CN2007800374012A patent/CN101610732B/zh not_active Expired - Fee Related
- 2007-10-05 US US12/444,367 patent/US8834577B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101610732A (zh) | 2009-12-23 |
| WO2008043484A3 (de) | 2008-05-29 |
| EP2079391A2 (de) | 2009-07-22 |
| US8834577B2 (en) | 2014-09-16 |
| US20100049330A1 (en) | 2010-02-25 |
| EP2079391B1 (de) | 2013-02-27 |
| DE102006047248B4 (de) | 2012-05-31 |
| JP2010505480A (ja) | 2010-02-25 |
| CN101610732B (zh) | 2013-05-01 |
| JP5099650B2 (ja) | 2012-12-19 |
| WO2008043484A2 (de) | 2008-04-17 |
| DE102006047248A1 (de) | 2008-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2407283T3 (es) | Distracción de callo óseo artificial tridimensional | |
| Del Bakhshayesh et al. | An overview of advanced biocompatible and biomimetic materials for creation of replacement structures in the musculoskeletal systems: focusing on cartilage tissue engineering | |
| ES2338464T3 (es) | Material compuesto, especialmente para uso medico, y procedimiento para producir el material. | |
| ES2700677T3 (es) | Composiciones para implante óseo que en un principio puede deformarse plásticamente | |
| US6991652B2 (en) | Tissue engineering composite | |
| ES2393403T3 (es) | Composición biocompatible para reemplazar o regenerar tejidos | |
| ES2877181T3 (es) | Reparación de cartílago articular | |
| ES2424146T3 (es) | Canal guía de nervios | |
| ES2315223T3 (es) | Crecimiento celular. | |
| JP2011518008A (ja) | 生体適合性インプラント | |
| US20190022273A1 (en) | Devices and compositions and methods of use thereof | |
| AU2015254542A1 (en) | Agent, product and use | |
| Cao et al. | Functional hydrogel interfaces for cartilage and bone regeneration | |
| ES2563240T3 (es) | Dispositivo médico flocado y métodos para la fabricación del dispositivo | |
| ES2336452T3 (es) | Material composite que contiene hidrogel, producido por precipitacion de una base solida desencadenada electricamente. | |
| BR112020022387A2 (pt) | composições de material para bioarcabouço | |
| Santos Jr | Bioresorbable polymers for tissue engineering | |
| US9050190B2 (en) | Device comprising a swelling agent and sheathing for artificial callus distraction | |
| US20140005794A1 (en) | Granulate mixture comprising two different granulates for artificial callus distraction | |
| ES2975538T3 (es) | Método para preparar un armazón tridimensional para uso médico | |
| US9144582B2 (en) | Granulated material mixture comprising two different granulated materials for artificial callus distraction | |
| Hofmann et al. | Bioactive scaffolds for the controlled formation of complex skeletal tissues | |
| TW202233260A (zh) | 多層膠原結構 | |
| Darling et al. | Bioactive scaffold design for articular cartilage engineering | |
| Sheikh et al. | Injectable Hydrogels for Cartilage and Bone Regeneration: Material Properties, Delivery Strategies, and Clinical Applications |